Phase II clinical trial of transcranial direct current stimulation in the treatment of primary progressive aphasia
经颅直流电刺激治疗原发性进行性失语症II期临床试验
基本信息
- 批准号:10522254
- 负责人:
- 金额:$ 150.09万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-30 至 2027-05-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAffectAftercareAgeAgingAllelesAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAnomiaAphasiaAreaAtrophicAttentionBDNF geneBehavioralBiologicalBrainBrain imagingCanadaCharacteristicsClinicalClinical ResearchClinical effectivenessCognitiveCollaborationsCommunicationCrossover DesignDegenerative DisorderDiseaseDouble-Blind MethodElderlyFailureFrontotemporal DementiaGenetic PolymorphismGoalsHealth SciencesImageImpairmentInferiorInternationalInterventionInvestigationLanguageLanguage DisordersLanguage TherapyLeftMagnetic Resonance ImagingMeasuresMembrane PotentialsMulti-Institutional Clinical TrialNamesNeurodegenerative DisordersNeurologicNeuronsNorth AmericaOralOutcomeParietalParticipantPatientsPennsylvaniaPerformancePersonsPharmaceutical PreparationsPhasePhase II Clinical TrialsPhase III Clinical TrialsPilot ProjectsPlacebosPopulationPositioning AttributePrevalencePrimary Progressive AphasiaProductionPublishingRandomizedResearchResearch PersonnelRestRiskSeveritiesSiteSynaptic TransmissionSynaptic plasticitySyndromeTechniquesTestingTherapeuticThickUniversitiesVariantWorkalternative treatmentarmbasebehavior testbilingualismclinical practicecognitive controlcohortcomputerizedeffective therapyexperienceimprovedneuroimagingneuroregulationnovelnovel therapeuticspatient populationpreventprimary outcomerelating to nervous systemresponsesexspellingsuccesssymptom treatmenttargeted treatment
项目摘要
Primary progressive aphasia (PPA), a debilitating condition of language loss associated with Alzheimer's Disease and Alzheimer's Disease Related Dementias (AD/ADRD) affecting many patients with frontotemporal dementia (FTD) and Alzheimer’s disease (AD), lacks effective treatments. One of the most common and burdensome impairments associated with this manifestation of AD/ADRD is anomia, the inability to access the names of objects, experienced by patients as word-finding difficulty. Transcranial direct current stimulation (tDCS), a form of noninvasive neuromodulation, shows promise as an intervention for anomia in persons with PPA. However, efforts to introduce this novel treatment approach into clinical practice are hampered by the modest size and scope of prior tDCS studies in this patient population, which prevents establishment of clear, robust clinical evidence to support the widespread use of tDCS in clinical contexts. To address this gap, this proposal aims to conduct the world’s first well-powered, multi-site Phase 2 clinical trial of tDCS therapy in PPA. In order to accomplish this goal, the current project solidifies a collaboration between research teams at Johns Hopkins, University of Pennsylvania, and Baycrest Health Sciences, which have collectively produced 100% of the published studies on tDCS in PPA in North America and 80% of the studies internationally. In a total cohort of 120 patients with PPA, we will employ a randomized, double-blind, within-subject, cross-over design similar to trials that have been previously employed at each of the contributing sites. Following baseline behavioral testing focused on language abilities and MRI imaging, subjects with PPA will receive 10 daily sessions over two weeks of either tDCS paired with NAming and SPelling treatment (NASP; a behavioral language therapy targeting both oral and written naming production) or sham (placebo) tDCS paired with NASP. Participants will undergo behavioral testing and imaging again at the end of the intervention, receive behavioral testing a month later, and then repeat testing and brain imaging 3 months after the end of the intervention. Participants will then switch study arms and receive the intervention, testing, and imaging at the same intervals. We will also conduct baseline behavioral testing and neuroimaging (with no treatment) on 60 neurologically healthy older adults for comparison to PPA subjects with respect to language performance and brain imaging. Subsequent analyses will determine whether tDCS over the left frontal language areas paired with naming treatment results in persistent improvement in oral and written naming, and will also identify the clinical, neural, biological, cognitive, and demographic characteristics that predict tDCS effects on naming performance. Owing to our unique opportunity to study a largely bilingual population in Canada, we will focus specific attention on bilingualism as a demographic feature that may influence outcomes. Overall, this impactful trial will provide the most reliable answer to date as to whether tDCS is effective for treating naming deficits in PPA and will help the field to identify patients best suited for this promising intervention in AD/ADRD.
原发性进行性失语症(PPA)是一种与阿尔茨海默病和阿尔茨海默病相关痴呆(AD/ADRD)相关的语言丧失的衰弱性病症,影响许多额颞叶痴呆(FTD)和阿尔茨海默病(AD)患者,缺乏有效的治疗方法。与AD/ADRD的这种表现相关的最常见和最沉重的障碍之一是命名障碍,患者无法获得物体的名称,表现为单词查找困难。经颅直流电刺激(tDCS),一种非侵入性神经调节的形式,显示出作为PPA患者命名障碍的干预措施的前景。然而,将这种新的治疗方法引入临床实践的努力受到了该患者人群中先前tDCS研究的适度规模和范围的阻碍,这阻碍了建立明确,可靠的临床证据来支持tDCS在临床环境中的广泛使用。为了解决这一差距,该提案旨在进行世界上第一个在PPA中进行tDCS治疗的良好动力,多中心2期临床试验。为了实现这一目标,目前的项目巩固了约翰霍普金斯,宾夕法尼亚大学和Baycrest Health Sciences的研究团队之间的合作,这些研究团队共同产生了100%的已发表的关于PPA中tDCS的北美研究和80%的国际研究。在总共120例PPA患者的队列中,我们将采用随机、双盲、受试者内、交叉设计,类似于之前在每个参与研究中心采用的试验。在重点关注语言能力和MRI成像的基线行为测试后,PPA受试者将在两周内接受10次每日一次的tDCS与命名和拼写治疗(NASP;一种针对口头和书面命名产生的行为语言治疗)或假(安慰剂)tDCS与NASP配对。参与者将在干预结束时再次接受行为测试和成像,一个月后接受行为测试,然后在干预结束后3个月重复测试和大脑成像。然后,参与者将转换研究组,并以相同的时间间隔接受干预,测试和成像。我们还将对60名神经系统健康的老年人进行基线行为测试和神经成像(无治疗),以与PPA受试者在语言表现和脑成像方面进行比较。随后的分析将确定是否tDCS在左额叶语言区配对命名治疗的结果在口头和书面命名的持续改善,还将确定预测tDCS对命名性能的影响的临床,神经,生物,认知和人口统计学特征。由于我们有独特的机会研究加拿大的双语人口,我们将特别关注双语作为可能影响结果的人口特征。总的来说,这项有影响力的试验将提供迄今为止最可靠的答案,即tDCS是否能有效治疗PPA中的命名缺陷,并将帮助该领域确定最适合这种有希望的AD/ADRD干预的患者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Roy H Hamilton其他文献
Disparities in Genetic Testing for Neurologic Disorders.
神经系统疾病基因检测的差异。
- DOI:
10.1212/wnl.0000000000209161 - 发表时间:
2024 - 期刊:
- 影响因子:9.9
- 作者:
A. Baldwin;Juliette Copeland;Meron Azage;Laynie Dratch;Kelsey Johnson;Rachel A Paul;Defne A. Amado;M. Baer;Andres Deik;Lauren B. Elman;Michael Guo;A. Hamedani;David J Irwin;Aaron Lasker;Jennifer Orthmann;Colin C. Quinn;T. Tropea;Steven S Scherer;Russell T Shinohara;Roy H Hamilton;Colin A Ellis - 通讯作者:
Colin A Ellis
Abstracts of Scientific Papers and Posters Presented at the Annual Meeting of the Association of Academic Physiatrists: New Orleans, Louisiana March 6 – 10, 2013
学术物理医师协会年会上发表的科学论文和海报摘要:路易斯安那州新奥尔良,2013 年 3 月 6 日至 10 日
- DOI:
- 发表时间:
2013 - 期刊:
- 影响因子:3
- 作者:
Steven A Mann;Dae Hyeon Kim;M. DiVita;Andrew G Reish;Michael Rhee;Roy H Hamilton;Preeti Sunderaraman;Kelli S Williams - 通讯作者:
Kelli S Williams
Roy H Hamilton的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Roy H Hamilton', 18)}}的其他基金
Phase II clinical trial of transcranial direct current stimulation in the treatment of primary progressive aphasia
经颅直流电刺激治疗原发性进行性失语症II期临床试验
- 批准号:
10705285 - 财政年份:2022
- 资助金额:
$ 150.09万 - 项目类别:
Treating primary progressive aphasia and elucidating neurodegeneration in the language network using transcranial direct current stimulation
使用经颅直流电刺激治疗原发性进行性失语症并阐明语言网络中的神经退行性变
- 批准号:
10450141 - 财政年份:2019
- 资助金额:
$ 150.09万 - 项目类别:
Treating primary progressive aphasia and elucidating neurodegeneration in the language network using transcranial direct current stimulation
使用经颅直流电刺激治疗原发性进行性失语症并阐明语言网络中的神经退行性变
- 批准号:
10201511 - 财政年份:2019
- 资助金额:
$ 150.09万 - 项目类别:
TMS as a Biomarker of Plasticity in Aphasia Recovery
TMS 作为失语症恢复可塑性的生物标志物
- 批准号:
8578928 - 财政年份:2013
- 资助金额:
$ 150.09万 - 项目类别:
TMS as a Biomarker of Plasticity in Aphasia Recovery
TMS 作为失语症恢复可塑性的生物标志物
- 批准号:
9097676 - 财政年份:2013
- 资助金额:
$ 150.09万 - 项目类别:
TMS as a Biomarker of Plasticity in Aphasia Recovery
TMS 作为失语症恢复可塑性的生物标志物
- 批准号:
8688215 - 财政年份:2013
- 资助金额:
$ 150.09万 - 项目类别:
TMS as a Biomarker of Plasticity in Aphasia Recovery
TMS 作为失语症恢复可塑性的生物标志物
- 批准号:
9304199 - 财政年份:2013
- 资助金额:
$ 150.09万 - 项目类别:
TMS to explore interhemispheric interactions and to treat aphasia and neglect
TMS 探索大脑半球间的相互作用并治疗失语症和忽视
- 批准号:
7531513 - 财政年份:2008
- 资助金额:
$ 150.09万 - 项目类别:
TMS to explore interhemispheric interactions and to treat aphasia and neglect
TMS 探索大脑半球间的相互作用并治疗失语症和忽视
- 批准号:
7620029 - 财政年份:2008
- 资助金额:
$ 150.09万 - 项目类别:
TMS to explore interhemispheric interactions and to treat aphasia and neglect
TMS 探索大脑半球间的相互作用并治疗失语症和忽视
- 批准号:
7806482 - 财政年份:2008
- 资助金额:
$ 150.09万 - 项目类别:
相似海外基金
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 150.09万 - 项目类别:
Training Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 150.09万 - 项目类别:
Standard Grant
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 150.09万 - 项目类别:
Standard Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 150.09万 - 项目类别:
Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 150.09万 - 项目类别:
Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 150.09万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 150.09万 - 项目类别:
Studentship
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 150.09万 - 项目类别:
Operating Grants
New Tendencies of French Film Theory: Representation, Body, Affect
法国电影理论新动向:再现、身体、情感
- 批准号:
23K00129 - 财政年份:2023
- 资助金额:
$ 150.09万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Protruding Void: Mystical Affect in Samuel Beckett's Prose
突出的虚空:塞缪尔·贝克特散文中的神秘影响
- 批准号:
2883985 - 财政年份:2023
- 资助金额:
$ 150.09万 - 项目类别:
Studentship